Lung Cancer

2 trends tracked about this subject — the full history, oldest to newest below.

▲ Peaking Health

Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing

The journal Nature Medicine has retracted a high-profile study examining the impact of daily treatment timing on lung cancer immunotherapy survival rates.

5 sources 5 articles v 3 1h ago

◼ Archived Business 🔮 fades ✓

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Pfizer’s experimental lung cancer drug sigvotatug vedotin has failed to meet its primary objective in a late-stage clinical trial.

5 sources 5 articles v 3 2d ago